Concord Medical Services Stock Earnings Per Share
CCM Stock | USD 0.58 0.08 16.00% |
Concord Medical Services fundamentals help investors to digest information that contributes to Concord Medical's financial success or failures. It also enables traders to predict the movement of Concord Stock. The fundamental analysis module provides a way to measure Concord Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Concord Medical stock.
Concord | Earnings Per Share |
Concord Medical Services Company Earnings Per Share Analysis
Concord Medical's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Concord Medical Earnings Per Share | (0.96) X |
Most of Concord Medical's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Concord Medical Services is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Concord Earnings Per Share Driver Correlations
Understanding the fundamental principles of building solid financial models for Concord Medical is extremely important. It helps to project a fair market value of Concord Stock properly, considering its historical fundamentals such as Earnings Per Share. Since Concord Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Concord Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Concord Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Competition |
Concord Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
According to the company disclosure, Concord Medical Services has an Earnings Per Share of -0.96 times. This is 111.47% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The earnings per share for all United States stocks is 130.77% higher than that of the company.
Concord Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Concord Medical's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Concord Medical could also be used in its relative valuation, which is a method of valuing Concord Medical by comparing valuation metrics of similar companies.Concord Medical is currently under evaluation in earnings per share category among related companies.
Concord Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Concord Medical from analyzing Concord Medical's financial statements. These drivers represent accounts that assess Concord Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Concord Medical's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 806.0M | 781.1M | 556.7M | 494.1M | 341.0M | 324.0M | |
Enterprise Value | 2.6B | 2.8B | 3.1B | 3.6B | 3.5B | 3.7B |
Concord Fundamentals
Return On Equity | -0.28 | ||||
Return On Asset | -0.048 | ||||
Profit Margin | (0.55) % | ||||
Operating Margin | (0.98) % | ||||
Current Valuation | 7.17 B | ||||
Shares Outstanding | 43.42 M | ||||
Shares Owned By Insiders | 17.99 % | ||||
Shares Owned By Institutions | 0.10 % | ||||
Number Of Shares Shorted | 14.54 K | ||||
Price To Earning | (3.90) X | ||||
Price To Book | 3.00 X | ||||
Price To Sales | 0.04 X | ||||
Revenue | 537.4 M | ||||
Gross Profit | (152.41 M) | ||||
EBITDA | (344.16 M) | ||||
Net Income | (297.66 M) | ||||
Cash And Equivalents | 157.39 M | ||||
Cash Per Share | 1.72 X | ||||
Total Debt | 1.04 B | ||||
Debt To Equity | 1.25 % | ||||
Current Ratio | 0.71 X | ||||
Book Value Per Share | (48.87) X | ||||
Cash Flow From Operations | (276.47 M) | ||||
Short Ratio | 0.64 X | ||||
Earnings Per Share | (0.96) X | ||||
Target Price | 1.2 | ||||
Number Of Employees | 727 | ||||
Beta | -0.17 | ||||
Market Capitalization | 21.72 M | ||||
Total Asset | 6.05 B | ||||
Retained Earnings | (4.06 B) | ||||
Working Capital | (1.33 B) | ||||
Current Asset | 1.51 B | ||||
Current Liabilities | 1.51 B | ||||
Net Asset | 6.05 B |
About Concord Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Concord Medical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Concord Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Concord Medical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Concord Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Concord Medical's short interest history, or implied volatility extrapolated from Concord Medical options trading.
Check out Concord Medical Piotroski F Score and Concord Medical Altman Z Score analysis. Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Concord Stock analysis
When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Revenue Per Share 12.302 | Quarterly Revenue Growth (0.23) | Return On Assets (0.05) | Return On Equity (0.28) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.